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Abstract
The spread through air spaces (STAS) has a main role in local recurrence of stage I lung adenocarcinomas (LAs), therefore its
presence might question sublobar resection as a therapeutic option. The aim of our study was to evaluate the distribution of STAS
in stage I LAs, to stratify patients according to local recurrence and to identify a group of patients who might be suitable for
sublobar surgery. Patients resected with LA were included. The presence of STAS was recorded on hematoxylin eosin stained
slides and clinicopathological data were obtained from medical charts. Overall survival (OS) and disease-free survival (DFS)
were registered. Statistical methods included Kruskal-Wallis tests, Kaplan-Meier analyses, log-rank tests and Cox-regressions.
292 patients were included. STAS was identified in 38.7% and 95.7% of micropapillary carcinomas showed STAS. Significant
correlation was found between STAS and high-grade patterns. Significant differences were found between OS andDFS estimates
of STAS0 and STAS1 cases (5-y-OS: 80.0% vs. 68.4%; 5-y-DFS: 71.1% vs. 57.1%). The presence of STASwas associated with
unfavorable prognosis in low and intermediate architectural grades, but not in high-grade. Multivariate analysis revealed that
architectural grade (HR(OS):2.09; HR(DFS):1.52) and STAS (HR(OS):1.51; HR(DFS):1.48) were independent prognostic markers in
stage I LA. Architectural grade combined with STAS was superior to other prognostic grades. The combination of architectural
grade and STAS proved to be a prognostic factor that is superior to previously introduced grading systems. Patients having low
and intermediate grade LAs without STAS might be eligible for sublobar resection.
Keywords Lung adenocarcinoma . Spread through airspaces (STAS) . Architectural grade . Lung sparing surgery . Sublobar
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Background
Despite the development of molecular targeted therapies and
immune checkpoint inhibitors for the treatment of pulmonary
adenocarcinoma, its outcome is still unfavorable [1]. Lobar
resection with lymph node dissection remains the most com-
mon curative therapy in stage I disease [2, 3]. There are sev-
eral studies in progress aiming to validate the utility of lung
sparing or sublobar resection for early stage lung adenocarci-
noma and to answer whether lung sparing resection for this
disease is only a function preserving or a curative treatment
option as well [4]. These ongoing Japanese trials have sug-
gested, that sublobar resection achieves local control and
recurrence-free survival in patients with radiologically nonin-
vasive lung cancer, with a maximum tumor diameter of ≤
2 cm and a solid tumor ratio of ≤ 0.25 defined with CT [4, 5].
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Spread through air spaces (STAS) is a recently described
pattern of invasion of lung neoplasms [6]. STAS represents
micropapillary clusters, solid nests or single cells beyond the
edge of the tumor invading into air spaces [7, 8]. STAS was
implemented in the 2015 World Health Organization
Classification of Lung Tumors, and in the 8th edition of the
Cancer Staging Manual of the American Joint Committee on
Cancer (AJCC), resulting in the refining of the definition of
tumor invasion and furthermore the criteria of in situ, mini-
mally invasive and invasive adenocarcinoma, as well [9, 10].
Although STAS is extensively studied nowadays, the
pathomechanism is yet unknown. Cellular dedifferentiation,
loss of cell membrane cohesion and mechanical impact by the
surgeon have been proposed in the etiology of STAS [11].
Though the development of STAS is debated, an unfavorable
prognostic impact on survival was demonstrated in lung ade-
nocarcinomaswith STAS by several reports [7, 12–16]. STAS
has been associated with adverse prognosis in early stage lung
adenocarcinomas in patients, who underwent sublobar resec-
tions [7, 17]. In contrast to these results, Uruga and coworkers
have not found such an impact in cases of sublobar surgery.
Even though, lobectomy is the standard therapy for lung
adenocarcinoma in early stage, the process itself might be
high-risk for patients with comorbidities, namely chronic ob-
structive lung diseases, bronchiectasis or severe cardiovascu-
lar diseases. Sublobectomy may be a treatment option for
these patients, in selected cases of lung adenocarcinoma lack-
ing STAS. The aim of our study was to evaluate the distribu-
tion of STAS among different subtypes of stage I lung adeno-
carcinoma; to analyze the impact of morphologic features and
prognostic systems on survival; to stratify patients according
to local recurrence and to identify a group of patients who are
suitable for lung sparing surgery.
Methods
Patients operated on at the Department of Surgery, University
of Szeged between 2004 and 2013 with stage I lung adeno-
carcinoma were included in our retrospective, consecutive se-
ries. Exclusion criteria were multicentric, metachronous or
metastatic tumors, variants of adenocarcinoma (namely inva-
sive mucinous, mixed invasive mucinous/non-mucinous, col-
loid, fetal, enteric adenocarcinoma and sarcomatoid carcino-
ma), patients who underwent lung cancer surgery in the pre-
vious 2 years, positive surgical margins, perioperative death,
metastasis to lymph nodes and vascular invasion.
All hematoxylin eosin slides of the patients included were
evaluated and revised if needed, according to the WHO
Classification of Lung Tumors [9]. The presence of STAS was
recorded by two pathologists (TZ, LT), who were blinded to
patients’ clinical outcome and discrepancies were discussed at a
multi-headed microscope (Olympus BX43, Tokyo, Japan).
STASwas defined as micropapillary structures or solid nests that
were present in the air spaces beyond the edge of the tumor, even
if in the first alveoli from tumor edge [7]. Figure 1 presents a
micropapillary adenocarcinoma with STAS. The intraalveolar
tumor clusters found distant from the tumor without alveolar
interconnection to the tumormass, random clusters of tumor cells
especially at the edges of the sample, jagged edges of tumor
clusters, linear strips of cells lifted off alveolar walls were iden-
tified as ex vivo artifacts [7, 11].
Clinical data, including gender, age, tumor localization,
type of surgery, smoking habits, site of recurrence and
follow-up data were obtained frommedical charts, meanwhile
additional histopathological features including presence of nu-
clear atypia, lymphovascular invasion and necrosis, and prog-
nostic systems, namely architectural grade, Kadota-grade and
Sica-grade were collected from histopathology reports. Stage I
was defined according to the 8th edition of the Cancer Staging
Manual by the AJCC [10], namely tumors with diameter ≤ 4
cm, without any metastasis (pT1a-b-c-pT2a-pN0-pM0).
Lymphadenectomy was part of the operation in all cases and
lymph nodes were examined histologically.
The follow-up of patients consisted of three-monthly phys-
ical examination, chest X-ray and abdominal ultrasonography
evaluation in the first 2 years, then every 6 months until the
fifth year. Chest CT was performed every 6 months for the
first 2 years, then 6 or 12 monthly, depending on the patient,
until the fifth year. In case of any suspicion of progression,
chest CT and abdominal ultrasonography were included. The
follow-up period ended on 31st August 2019.
Concerning the statistical correlation of STAS and sub-
types of adenocarcinoma, the Kruskal-Wallis test was applied.
The impact of STAS on DFS and OS was assessed by the
Kaplan-Meier method. The log-rank test was used for
pairwise comparisons. Univariate and multivariate Cox re-
gressions were utilized for analyzing the clinicopathological
variables. All statistical tests were two-sided, and p < 0.05
values were considered statistically significant. The SPSS
Statistics software (IBM, SSPS 23.0, Armonk, NY USA)
was used for the analyses.
This retrospective study was approved by the institutional
ethical committee of the Albert Szent-Györgyi Clinical Centre
of the University of Szeged (ethical approval: 58/2020-SZTE).
Results
Altogether 292 patients matched the inclusion criteria. The
average age of patients with stage I lung adenocarcinoma
was 62.7 years (median: 62.3 years, range: 32–86). Relevant
clinical data are presented in Table 1. No gender predilection
was found in our series. Most patients were treated with lo-
bectomy and most were actual or previous heavy smokers for
2452 Zombori et al.
decades. The most frequent subtype was solid adenocarcino-
ma, followed by lepidic adenocarcinoma. Lymphovascular
spread was identified in nearly every fourth case and more
than half of the cases were diagnosed with stage IA disease.
The median follow-up was 75.7 months (range: 12–187
months). Tumor specific death was observed in 81 patients,
while recurrence was detected in 110 cases. In the latter group,
clinical information was available in 72 cases about the site of
recurrence. Recurrence in hilar or mediastinal lymph nodes, in
lungs and disseminated disease were found in 10 (13.9%), 21
(29.2%) and in 41 (56.9%) cases, respectively. The mean and
median of OS and DFS were 58.6 months, 52.4 months and
57.1 months 54.3 months, respectively.
Table 2 displays the distribution of STAS among lung ad-
enocarcinomas. STASwas identified in more than one third of
all cases (n = 113; 38.7%); though it was present in all sub-
types, STAS was found in more than 95% of micropapillary
carcinomas.
Pulmonary adenocarcinomas have more than one growth
pattern in 80% of the cases. All growth pattern components
were recorded in all cases. In tumors with STAS, the presence
of micropapillary pattern was frequent (85.3%), followed by
solid pattern as the second most common pattern (37.4%).
Tumors with STAS were associated with high-grade
(micropapillary or solid) growth pattern components in
91.7% of the cases. The Kruskal-Wallis test revealed signifi-
cant correlation between STAS and high-grade growth pat-
terns (p < 0.001).
In univariate Cox regression, subtype, presence of nuclear
atypia, lymphovascular spread and STAS were found signif-
icant prognosticators (Table 1). Regarding the findings of the
log rank test, significant differences were observed between
OS and DFS estimates of cases with STAS and without STAS
(5-y-OS: 80.0% vs. 68.4%; p = 0.045; 5-y-DFS: 71.1% vs.
57.1% p = 0.043), respectively. The prognostic impact of
STAS was evaluated in each architectural grade, as well
(Table 3). The presence of STAS was associated with unfa-
vorable prognosis in low (p(OS) = 0.04; p(DFS) = 0.034) and
intermediate architectural grade (p(DFS) = 0.04), but not in
high-grade. Multivariate analysis revealed that architectural
grade (p(OS) < 0.001; HR:2.09 95%CI:1.41–2.84; p(DFS) =
0.003; HR:1.52 95%CI:1.15–2.01) and STAS (p(OS) = 0.041;
HR:1.51 95%CI:1.12–2.31; p(DFS) = 0.045; HR:1.48
95%CI:1.19–2.03) were independent prognostic factors in
stage I lung adenocarcinoma.
Figure 2 demonstrates that adenocarcinomas having high-
grade morphology and/or STAS are associated with unfavor-
able prognosis, while tumors lacking these features have a
more favorable outcome (p(OS) < 0.001, p(DFS) < 0.001).
Identification of high-risk patients (grade 3 and/or STAS1)
and those with low-risk for recurrence and tumor-related death
(grade 1–2&STAS0) can become a powerful prognosticator.
In a previous study, the available grading systems were
compared and correlated with survival data, and the archi-
tectural grade was found the most optimal grading system
describing prognosis [18]. The multivariate analysis of
architectural grade, Kadota-grade, Sica-grade and archi-
tectural grade combined with STAS has shown
(Supplementary table 1), that the architectural grade com-
bined with STAS is superior to the other prognostic sys-
tems (p(OS) = 0.012; HR:2.98 95%CI:1.31–6.92; p(DFS) =
0.009; HR:2.29 95%CI:1.21–4.04).
Fig. 1 a Micropapillary
adenocarcinoma at small
magnification (HE, 10x); b
Presence of intraalveolar atypical
tumor cells (arrow) beyond the
border of the tumor (HE, 20x); c
Cluster of tumor cells (arrow) at
high magnification (HE, 40x)
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Discussion
In keeping with previous studies, STAS was diagnosed in
more than one third of all cases in our series [2, 7, 12, 13,
19]. The phenomenon was first described by Onozato and
coworkers [20]. Using three dimensional mapping of the
resected tumor, it was demonstrated that the areas of dissoci-
ated tumor cells are connected to each other and the main
tumor mass, as well. Kadota et al. have proposed that this
intraalveolar dissemination of tumor cells, namely STAS is a
form of invasion [7]. Several studies have been published
recently aiming at the validation of the prognostic impact of
STAS. Warth and coworkers have found that STAS is a prog-
nostic feature in all stages of lung adenocarcinoma [8].
Although the prognostic importance of STAS has been
demonstrated, its development is still debated. The process
Table 1 Clinicopathological
characteristics of patients
evaluated and results of univariate
Cox regression regarding the
different variables
Clinicopathological data n % OS DFS
p HR 95%CI p HR 95%CI
Gender 0.22 0.76 0.48–1.17 0.41 0.85 0.58–1.24
Female 154 52.7
Male 138 47.3
Localization 0.68 1.09 0.69–1.72 0.2 1.2 0.87–1.86
Left 181 62
Right 111 38
Type of surgery < 0.001 3.53 1.97–6.36 < 0.001 2.98 1.74–5.11
Lobar resection 266 91.1
Sublobar resection 26 8.9
Smoking habits 0.006 2.84 1.35–5.96 0.001 2.97 1.56–5.60
Heavy smoker 132 45.2
Never 38 13
No data 122 41.8






Necrosis 0.17 1.35 0.87–2.10 1.24 1.34 0.92–1.95
presence 133 45.5
absence 159 54.5
Lymphatic invasion 0.05 1.61 1.00-2.60 0.27 1.27 0.82–1.95
presence 68 23.3
absence 224 76.7
STAS 0.04 1.53 1.10–2.43 0.04 1.47 1.01–2.13
presence 123 42.1
absence 169 57.9





Stage < 0.001 1.5 1.20–1.81 < 0.001 1.18 1.02–1.43
IA1-3 182 62.3
IB 110 37.7
OS: overall survival, DFS: disease-free survival, HR: hazard ratio, 95%CI: 95% confidence interval, STAS:
spread through air spaces
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of dedifferentiation may alter the expression of genes in can-
cer cells, resulting in divergent features compared to the initial
cells. The adhesion between tumor cells may disrupt due to
the process of dedifferentiation, resulting in discohesive cell
clusters floating in the alveoli. These free-floating tumor cell
clusters may deposit on the alveolar wall and induce stromal
reaction and nidus formation. This theory supports the bad
prognostic impact of STAS [11]. In contrast, some authors
have an alternative explanation, namely that STAS is an arti-
fact [21, 22]. Thunnissen and coworkers have introduced the
concept of the spread through a knife surface (STAKS). They
have demonstrated that artificial displacement during a knife
cut is a real phenomenon, resulting in an increase of the num-
ber of intraalveolar tumor cell clusters with each sequential cut
[21]. In keeping with the results of Thunnissen, Blaauwgeers
et al. have found that less intraalveolar cell clusters are present
in cases of fewer sections, meanwhile more floating cells were
detected in specimens of sequential sectioning with the same
prosecting blade [22]. Despite the theory of STAKS, our find-
ings are in correspondence with others [12–16], namely STAS
is an independent prognostic factor in stage I lung
adenocarcinoma.
Lung adenocarcinomas with STAS are present mostly in
male patients and are associated with high- grade histology,
higher stage, lymphovascular spread and lymph node metasta-
sis. STAS has been related with more frequent locoregional
recurrence in sublobar resections [23, 24]. Regarding targetable
molecular alterations, adenocarcinomas with STAS have been
related to wild type epidermal growth factor receptor (EGFR)
[12, 25, 26], ALK rearrangement [23, 26] and Kirsten rat sar-
coma viral oncogene homolog (KRAS) mutation [20].
In consistency with others’ results [27–31], high architec-
tural grade (solid and micropapillary tumors) was associated
with an unfavorable outcome in our study. Furthermore, even
a subdominant component of high-grade pattern is related to
higher recurrence rate and tumor-related death [32].
We have demonstrated that patients having stage I lung
adenocarcinomas with high architectural grade (solid and
micropapillary carcinomas) and adenocarcinomas with
STAS are at high-risk of recurrence and tumor-specific death,
while patients having low- and intermediate-grade tumors
without STAS have a more favorable outcome (p(OS) <
0.001, p(DFS) < 0.001). Furthermore, the combination of archi-
tectural grade with STAS was proven to be a prognostic sys-
tem, superior to the previously tested architectural grade,
Kadota-grade and Sica-grade. Patients having stage I, low-
or intermediate-grade lung adenocarcinoma without STAS
might be suitable for lung sparing surgery.
Being a histopathological feature, the preoperative detec-
tion of STAS is controversial. Core needle biopsy specimen
might be able to reveal STAS preoperatively, however, there
is a high chance of sampling error with this method.
Unfortunately, bronchoalveolar lavage does not extract signif-
icant number of tumor cells for cytological examinations [33].
Another option is the evaluation of STAS and high-grade
morphology on intraoperative frozen sections. Yeh and co-
workers have evaluated the sensitivity and specificity of the
growth pattern recognition on intraoperative frozen sections.
They reported a sensitivity of 69% for solid, and 37% for
Table 3 The overall and disease-
free survival estimates and the re-
sults of univariate Cox regression,
regarding the different architec-
tural grades with or without
STAS
n OS (%) pOS HROS 95%CI DFS (%) pDFS HRDFS 95%CI
G1
STAS0 37 96.7 0.04 4.73 1.01–22.5 93.9 0.034 3.21 1.1–9.42
STAS1 27 80 68.8
G2
STAS0 58 89.4 0.12 2.23 0.80–6.17 78.9 0.04 2.03 1.1–4.2
STAS1 40 76.6 56.9
G3
STAS0 74 64.7 0.58 1.16 0.68–1.98 57.4 0.92 1.02 0.62–1.68
STAS1 56 56.8 51.7
G1: lepidic adenocarcinoma, G2: acinar and papillary adenocarcinoma, G3: solid and micropapillary adenocar-
cinoma, STAS: spread through air spaces, OS: overall survival, DFS: disease-free survival
Table 2 Distribution of STAS according to predominant growth
patterns of lung adenocarcinoma
Predominant growth pattern STAS1 STAS0
n % n %
Solid 32 29.6 76 70.4
Micropapillary 22 95.7 1 4.3
Acinar 20 37.7 33 62.3
Papillary 16 36.4 28 63.6
Lepidic 23 35.9 41 64.1
STAS: spread through air spaces; STAS1: STAS present; STAS0: STAS
absent
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micropapillary patterns, with a specificity of 96% and 97%,
respectively [34]. Eguchi et al. observed the demonstrability
of STAS on intraoperative frozen sections with a sensitivity of
71% and a specificity of 92% for detecting STAS [24].
Prospective studies are required for the evaluation of sensitiv-
ity and specificity of detecting tumors with high-grade morphol-
ogy and/or STAS on frozen sections.Multiple frozen sections are
needed due to the fact, that two features have to be defined,
namely the growth pattern of the tumor and the presence of
STAS in the surrounding lung parenchyma. Morimoto and co-
workers have demonstrated, that STAS around the tumor is pres-
ent in an area that is smaller than the diameter of the tumor,
furthermore STAS was not present in the area of lung parenchy-
ma farther than 7.3 mm from the edges of the tumor [35].
Therefore, at least two frozen sections are required, one from
the tumor mass and one from its neighboring lung parenchyma.
In selected patients having stage I lung adenocarcinoma,
lung sparing surgery might be a treatment option, if high ar-
chitectural grade and STAS are not detected in the preopera-
tive biopsy and on the intraoperative frozen section. If either
high-grademorphology or STAS is present in the preoperative
biopsy, primary lobectomy should be performed. If these
components are identified during intraoperative examination,
completing lobectomy can be suggested in one session.
The retrospective nature of the series, being a single-
institutional study, the lack of evaluation of surgical margins
and molecular alterations, the low number of sublobar resec-
tions and the exclusion of cases with vascular invasionmay be
limitations. The cases with positive resectionsmargins are rare
in our center in stage I adenocarcinomas, therefore these cases
were excluded. The low rate of sublobar resections is due to
international and national guidelines [36, 37]. The tumors
demonstrating vascular invasion have an unfavorable
prognosis even in small tumors [38], therefore these
cases were excluded as well.
Our study has also strengths: it is based on a relatively large
cohort; tumors were sliced with prosecting blades cleaned
before each slice, aiming at the minimization of the STAKS
effect; and the definition of STAS and the exclusion of arti-
facts were rigorously applied.
In our retrospective study of consecutive stage I adenocar-
cinomas, STAS was proven as a significant prognostic factor
in univariate analysis. Architectural grade and STAS were
independent prognostic factors in multivariate analysis, as
well. The combination of architectural grade with STAS re-
sulted in a prognostic system superior to previously intro-
duced grading systems. Patients having low- and
intermediate-grade lung adenocarcinomas without STAS
might be candidates for lung sparing surgery.
Author Contributions Tamás Zombori: conception, data collection, sta-
tistical analysis, draft of manuscript, revision.
Anita Sejben: data collection, statistical analysis, draft of manuscript,
revision.
László Tiszlavicz: data collection, draft of manuscript, revision.
Gábor Cserni: draft of manuscript, revision.
Regina Pálföldi: data collection, draft of manuscript, revision.
Edit Csada: data collection, draft of manuscript revision.
József Furák: conception, data collection, draft of manuscript,
revision.
Funding Information Open access funding provided by University of
Szeged.
Data Availability The datasets generated during and/or analysed during
the current study are available from the corresponding author on reason-
able request.
Compliance with Ethical Standards
Conflict of Interest No editorial or financial conflicts of interest exist for
this submission.
Fig. 2 Kaplan-Meier test of architectural grade combined with STAS.
The low- and intermediate-grade lung adenocarcinomas without STAS
[G1-2&STAS0] have more favorable outcome than high-grade
adenocarcinomas and/or adenocarcinomas with STAS [G3 / STAS1]
(pOS<0.001, pDFS<0.001)
2456 Zombori et al.
Ethics Approval This retrospective study was approved by the institu-
tional ethical committee of the Albert Szent-Györgyi Clinical Centre of
the University of Szeged (ethical approval: 58/2020-SZTE).
Consent for Publication Not applicable.
Consent to Participate Not applicable.
Code Availability There are no restrictions on the availability of mate-
rials, data and code.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as
long as you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons licence, and indicate if
changes weremade. The images or other third party material in this article
are included in the article's Creative Commons licence, unless indicated
otherwise in a credit line to the material. If material is not included in the
article's Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will
need to obtain permission directly from the copyright holder. To view a
copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
References
1. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA
Cancer J Clin 69:7–34. https://doi.org/10.3322/caac.21551
2. Toyokawa G, Yamada Y, Tagawa T, Oda Y (2018) Significance of
spread through air spaces in early-stage lung adenocarcinomas un-
dergoing limited resection. Thorac Cancer 9:1255–1261. https://
doi.org/10.1111/1759-7714.12828
3. Ginsberg RJ, Rubinstein LV (1995) Randomized trial of lobectomy
versus limited resection for T1 N0 non-small cell lung cancer. Lung
Cancer Study Group. Ann Thorac Surg 60:615–622
4. Aokage K, Yoshida J, Hishida T, Tsuboi M, Saji H, Okada M,
Suzuki K, Watanabe S, Asamura H (2017) Limited resection for
early-stage non-small cell lung cancer as function-preserving radi-
cal surgery: a review. Jpn J Clin Oncol 47:7–11. https://doi.org/10.
1093/jjco/hyw148
5. Suzuki K, Watanabe S, Wakabayashi M, Moriya Y, Yoshino I,
Tsuboi M, Mitsudomi T, Asamura H (2017) A nonrandomized
confirmatory phase III study of sublobar surgical resection for pe-
ripheral ground glass opacity dominant lung cancer defined with
thoracic thin-section computed tomography (JCOG0804/
WJOG4507L). J Clin Oncol 35: Abstract 8561
6. Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM,
BeasleyMB, Chirieac LR, Dacic S, Duhig E, Flieder DB, Geisinger
K, Hirsch FR, Ishikawa Y, Kerr KM, Noguchi M, Pelosi G, Powell
CA, Tsao MS, Wistuba I, WHO Panel (2015) The 2015 World
Health Organization classification of lung tumors: Impact of genet-
ic, clinical and radiologic advances since the 2004 Classification. J
Thorac Oncol 10:1243–1260. https://doi.org/10.1097/JTO.
0000000000000630
7. Kadota K, Nitadori J, Sima CS, Ujiie H, Rizk NP, Jones DR,
Adusumilli PS, TravisWD (2015) Tumor spread through air spaces
is an important pattern of invasion and impacts the frequency and
location of recurrences after limited resection for small stage I lung
adenocarcinomas. J Thorac Oncol 10:806–814. https://doi.org/10.
1097/JTO.0000000000000486
8. Warth A (2017) Spread through air spaces (STAS): a comprehen-
sive update. Transl Lung Cancer Res 6:501–507. https://doi.org/10.
21037/tlcr.2017.06.08
9. TravisWD, Brambilla E, Burke AP,MarxA, Nicholson AG (2015)
WHO classification of tumours of the lung, pleura, thymus and
heart. Fourth edition. International Agency for Research on
Cancer, Lyon
10. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK,
Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL,
Balch CM, Winchester DP, Asare EA, Madera M, Gress DM,
Meyer LR (2018) AJCC Cancer Staging Manual. Vol xvii. 8th
ed. Springer International Publishing, Cham
11. Shih AR, Mino-Kenudson M (2020) Updates on spread through air
spaces (STAS) in lung cancer. Histopathology. https://doi.org/10.
1111/his.14062
12. Shiono S, Yanagawa N (2016) Spread through air spaces is a pre-
dictive factor of recurrence and a prognostic factor in stage I lung
adenocarcinoma. Interact Cardiovasc Thorac Surg 23:567–572.
https://doi.org/10.1093/icvts/ivw211
13. Uruga H, Fujii T, Fujimori S, Kohno T, Kishi K (2017)
Semiquantitative assessment of tumor spread through air spaces
(STAS) in early-stage lung adenocarcinomas. J Thorac Oncol 12:
1046–1051. https://doi.org/10.1016/j.jtho.2017.03.019
14. Kadota K, Kushida Y, Katsuki N, Ishikawa R, Ibuki E, Motoyama
M, Nii K, Yokomise H, Bandoh S, Haba R (2017) Tumor spread
through air spaces is an independent predictor of recurrence-free
survival in patients with resected lung squamous cell carcinoma.
Am J Surg Pathol 41:1077–1086. https://doi.org/10.1097/PAS.
0000000000000872
15. Lu S, Tan KS, Kadota K, Eguchi T, Bains S, Rekhtman N,
Adusumilli PS, Travis WD (2017) Spread through air spaces
(STAS) is an independent predictor of recurrence and lung
cancer-specific death in squamous cell carcinoma. J Thorac Oncol
12:223–234. https://doi.org/10.1016/j.jtho.2016.09.129
16. Morimoto J, Nakajima T, Suzuki H, Nagato K, Iwata T, Yoshida S,
Fukuyo M, Ota S, Nakatani Y, Yoshino I (2016) Impact of free
tumor clusters on prognosis after resection of pulmonary adenocar-
cinoma. J Thorac Cardiovasc Surg 152:64–72.e1. https://doi.org/
10.1016/j.jtcvs.2016.03.088
17. Shiono S, EndoM, Suzuki K, Yarimizu K, Hayasaka K, Yanagawa
N (2018) Spread through air spaces is a prognostic factor in
sublobar resection of non-small cell lung Cancer. Ann Thorac
Surg 106:354–360. https://doi.org/10.1016/j.athoracsur.2018.02.
076
18. Zombori T, Furák J, Nyári T, Cserni G, Tiszlavicz L (2018)
Evaluation of grading systems in stage I lung adenocarcinomas: a
retrospective cohort study. J Clin Pathol 71:135–140. https://doi.
org/10.1136/jclinpath-2016-204302
19. Dai C, Xie H, Su H, She Y, Zhu E, Fan Z, Zhou F, Ren Y, Xie D,
Zheng H, Kadeer X, Chen D, Zhang L, Jiang G, Wu C, Chen C
(2017) Tumor spread through air spaces affects the recurrence and
overall survival in patients with lung adenocarcinoma > 2 to 3 cm. J
Thorac Oncol 12:1052–1060. https://doi.org/10.1016/j.jtho.2017.
03.020
20. OnozatoML, Kovach AE, Yeap BY,Morales-Oyarvide V, Klepeis
VE, Tammireddy S, Heist RS, Mark EJ, Dias-Santagata D, Iafrate
AJ, Yagi Y, Mino-Kenudson M (2013) Tumor islands in resected
early-stage lung adenocarcinomas are associated with unique clin-
icopathologic and molecular characteristics and worse prognosis.
Am J Surg Pathol 37:287–294. https://doi.org/10.1097/PAS.
0b013e31826885fb
21. Thunnissen E, Blaauwgeers HJ, de Cuba EM,Yick CY, Flieder DB
(2016) Ex vivo artifacts and histopathologic pitfalls in the lung.
Arch Pathol Lab Med 140:212–220. https://doi.org/10.5858/arpa.
2015-0292-OA
2457Architectural Grade Combined With Spread Through Air Spaces (STAS) Predicts Recurrence and is Suitable for...
22. Blaauwgeers H, Flieder D,Warth A, Harms A,Monkhorst K,Witte
B, Thunnissen E (2017) A prospective study of loose tissue frag-
ments in non-small cell lung cancer resection specimens: An alter-
native view to “spread through air spaces”. Am J Surg Pathol 41:
1226–1230. https://doi.org/10.1097/PAS.0000000000000889
23. Kadota K, Kushida Y, Kagawa S, Ishikawa R, Ibuki E, Inoue K, Go
T, Yokomise H, Ishii T, Kadowaki N, Haba R (2019) Limited
resection is associated with a higher risk of locoregional recurrence
than lobectomy in stage I lung adenocarcinoma with tumor spread
through air spaces. Am J Surg Pathol 43:1033–1041. https://doi.
org/10.1097/PAS.0000000000001285
24. Eguchi T, KamedaK, Lu S, BottMJ, Tan KS,Montecalvo J, Chang
JC, Rekhtman N, Jones DR, Travis WD, Adusumilli PS (2019)
Lobectomy is associated with better outcomes than sublobar resec-
tion in spread through air spaces (STAS)-positive T1 lung adeno-
carcinoma: A Propensity score-matched analysis. J Thorac Oncol
14:87–98. https://doi.org/10.1016/j.jtho.2018.09.005
25. Warth A, Muley T, Kossakowski CA, Goeppert B, Schirmacher P,
Dienemann H, Weichert W (2015) Prognostic impact of intra-
alveolar tumor spread in pulmonary adenocarcinoma. Am J Surg
Pa t ho l 39 : 793–801 . h t t p s : / / do i . o r g / 10 . 1097 /PAS .
0000000000000409
26. Lee JS, Kim EK, KimM, Shim HS (2018) Genetic and clinicopath-
ologic characteristics of lung adenocarcinoma with tumor spread
through air spaces. Lung Cancer 123:121–126. https://doi.org/10.
1016/j.lungcan.2018.07.020
27. Kadota K, Yeh YC, Sima CS, Rusch VW,Moreira AL, Adusumilli
PS, Travis WD (2014) The cribriform pattern identifies a subset of
acinar predominant tumors with poor prognosis in patients with
stage I lung adenocarcinoma: a conceptual proposal to classify crib-
riform predominant tumors as a distinct histologic subtype. Mod
Pathol 27:690–700. https://doi.org/10.1038/modpathol.2013.188
28. Kadota K, Kushida Y, Kagawa S, Ishikawa R, Ibuki E, Inoue K, Go
T, Yokomise H, Ishii T, Kadowaki N, Haba R (2019) Cribriform
subtype is an independent predictor of recurrence and survival after
adjustment for the eighth edition of TNM staging system in patients
with resected lung adenocarcinoma. J Thorac Oncol 14:245–254.
https://doi.org/10.1016/j.jtho.2018.09.028
29. Yanagawa N, Shiono S, Abiko M, Katahira M, Osakabe M, Ogata
SY (2016) The clinical impact of solid and micropapillary patterns
in resected lung adenocarcinoma. J Thorac Oncol 11:1976–1983.
https://doi.org/10.1016/j.jtho.2016.06.014
30. Cha MJ, Lee HY, Lee KS, Jeong JY, Han J, Shim YM, Hwang HS
(2014) Micropapillary and solid subtypes of invasive lung adeno-
carcinoma: clinical predictors of histopathology and outcome. J
Thorac Cardiovasc Surg 147:921–928.e2. https://doi.org/10.1016/
j.jtcvs.2013.09.045
31. Hung JJ, Yeh YC, JengWJ,Wu KJ, Huang BS,Wu YC, Chou TY,
HsuWH (2014) Predictive value of the international association for
the study of lung cancer/American Thoracic Society/European
Respiratory Society classification of lung adenocarcinoma in tumor
recurrence and patient survival. J Clin Oncol 32:2357–2364. https://
doi.org/10.1200/JCO.2013.50.1049
32. Zombori T, Nyári T, Tiszlavicz L, Pálföldi R, Csada E, Géczi T,
Ottlakán A, Pécsy B, Cserni G, Furák J (2018) The more the
micropapillary pattern in stage I lung adenocarcinoma, the worse
the prognosis-a retrospective study on digitalized slides. Virchows
Arch 472:949–958. https://doi.org/10.1007/s00428-018-2337-x
33. Medina MA, Onken AM, de Margerie-Mellon C, Heidinger BH,
Chen Y, Bankier AA, VanderLaan PA (2020) Preoperative bron-
chial cytology for the assessment of tumor spread through air spaces
in lung adenocarcinoma resection specimens. Cancer Cytopathol
128:278–286. https://doi.org/10.1002/cncy.22243
34. Yeh YC, Nitadori J, Kadota K, Yoshizawa A, Rekhtman N,
Moreira AL, Sima CS, Rusch VW, Adusumilli PS, Travis WD
(2015) Using frozen section to identify histological patterns in stage
I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver
agreement. Histopathology 66:922–938. https://doi.org/10.1111/
his.12468
35. Morimoto J, Nakajima T, Suzuki H, Nagato K, Iwata T, Yoshida S,
Fukuyo M, Ota S, Nakatani Y, Yoshino I (2016) Impact of free
tumor clusters on prognosis after resection of pulmonary adenocar-
cinoma. J Thorac Cardiovasc Surg 152:64–72.e1. https://doi.org/
10.1016/j.jtcvs.2016.03.088
36. Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA,
Vansteenkiste J, Escriu C, Peters S, ESMO Guidelines
Committee (2017) Early and locally advanced non-small-cell lung
cancer (NSCLC): ESMOClinical practice guidelines for diagnosis,




38. Tsubokawa N,Mimae T,Miyata Y, Sasada S, Yoshiya T, Kushitani
K, Takeshima Y, Murakami S, Yokose T, Ito H, Nakayama H,
Okada M (2016) Prognostic significance of vascular invasion in
intermediate-grade subtype of lung adenocarcinoma. Jpn J Clin
Oncol 46:1015–1021. https://doi.org/10.1093/jjco/hyw113
Publisher's Note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
2458 Zombori et al.
